Actively Recruiting
Immunotherapy in Lymphoma
Led by Sung-Soo Park · Updated on 2025-01-28
72
Participants Needed
2
Research Sites
79 weeks
Total Duration
On this page
Sponsors
S
Sung-Soo Park
Lead Sponsor
Y
Yeouido St. Mary's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to compare the efficacy of advanced immunochemotherapy and classical immunochemotherapy in relapsed/refractory high grade B cell lymophoma patients. The main question it aims to answer is: Does advanced immunochemotherapy, including CAR-T therapy, bispecific antibody, and antibody-drug conjugate offer superior survival outcomes than when treated with classical immunochemotherapy, such as proteasome inhibitors, immune modulatory drugs, and monoclonal antibodies? Researchers will compare patients receiving advanced immunochemotherapy with those receiving classical immunochemotherapy to determine if advanced therapies result in better survival outcomes. Laboratory findings and electronic medical records (EMR) from participants will be used to assess survival outcomes and treatment-related safety profiles.
CONDITIONS
Official Title
Immunotherapy in Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 to 74 years
- Diagnosed after January 2015 with diffuse large B cell lymphoma, primary mediastinal large B cell lymphoma, high grade B cell lymphoma, or Burkitt lymphoma
- Have received immunochemotherapy treatment for relapsed or refractory lymphoma
You will not qualify if you...
- Progression to acute leukemia
- Development of solid tumor during treatment
- Active infections including acute pneumonia, viral infections, active hepatitis B, or active pulmonary tuberculosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Seoul St. Mary Hospital
Seoul, South Korea, 06591
Actively Recruiting
2
Yeoido St. Mary Hospital
Seoul, South Korea, 07345
Actively Recruiting
Research Team
S
Sung-Soo Park, MD. PhD.
CONTACT
Y
Young-Woo Jeon, MD. PhD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here